NCI Definition: Carcinoma that arises from the laryngeal epithelium. More than 90% of laryngeal carcinomas are squamous cell carcinomas. The remainder are adenoid cystic carcinomas, mucoepidermoid carcinomas and carcinomas with neuroendocrine differentiation. [1]

Laryngeal carcinomas most frequently harbor alterations in TP53, CDKN2A, PIK3CA, KMT2D, and CCND1 [2].

Most Commonly Altered Genes in Laryngeal Carcinoma

TP53 Mutation, TP53 c.217-c.1178 Missense, TP53 Missense, PIK3CA Mutation, and TP53 Exon 5 Mutation are the most common alterations in laryngeal carcinoma [2].

Top Alterations in Laryngeal Carcinoma

Disease Details

Carcinoma of the Larynx, Cancer of the Larynx, Larynx Carcinoma, Laryngeal Cancer, Carcinoma of Larynx, Cancer of Larynx
Malignant Laryngeal Neoplasm
Laryngeal Squamous Cell Carcinoma, Supraglottic Carcinoma, Glottis Carcinoma, Laryngeal Mucoepidermoid Carcinoma, Laryngeal Small Cell Carcinoma, Laryngeal Adenoid Cystic Carcinoma, Subglottic Carcinoma, and Laryngeal Adenosquamous Carcinoma


1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.